Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age22-38
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

The aim of this study is to verify the efficacy of in vitro induction of autologous decidual-like NK cells therapy for reproductive failure associated with uterine NK cells abnormalities.

Eligibility criteria

Qualifiers

Reproductive failure with abnormal endometrial natural killer (NK) cells in menstrual blood;

With a clear intention to conceive;

Normal ovarian function, or premature ovarian insufficiency with ≥2 high-quality cryopreserved embryos available for transfer;

Endometrial thickness measured by transvaginal ultrasound during the periovulatory period ≥7 mm;

Disqualifiers

Use of progesterone receptor modulators;

One of the couple's chromosomal karyotype abnormalities, with no euploid embryo identified via preimplantation genetic testing for aneuploidy;

Severe endometriosis or adenomyosis, uterine fibroids affecting uterine cavity morphology, uterine malformations, intrauterine adhesions, or thin endometrium;

Uncontrolled autoimmune or endocrine disorders;

Trial design

Treatments tested in this trial

  • NK cell perfusion group

Treatment groups

159 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Lead sponsor

The University of Science and Technology of China

Collaborator

Sir Run Run Shaw Hospital

Collaborator

Second Affiliated Hospital of Soochow University

Collaborator

The First Affiliated Hospital of Anhui Medical University

Collaborator

The First Affiliated Hospital of University of Science and Technology of China

Collaborator